DK3541784T5 - Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission - Google Patents
Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission Download PDFInfo
- Publication number
- DK3541784T5 DK3541784T5 DK17807779.8T DK17807779T DK3541784T5 DK 3541784 T5 DK3541784 T5 DK 3541784T5 DK 17807779 T DK17807779 T DK 17807779T DK 3541784 T5 DK3541784 T5 DK 3541784T5
- Authority
- DK
- Denmark
- Prior art keywords
- modulators
- derivatives useful
- azetidine derivatives
- novel azetidine
- cortical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16199545 | 2016-11-18 | ||
| PCT/EP2017/079666 WO2018091687A1 (en) | 2016-11-18 | 2017-11-17 | Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK3541784T3 DK3541784T3 (en) | 2023-10-23 |
| DK3541784T5 true DK3541784T5 (da) | 2024-09-16 |
Family
ID=57348567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17807779.8T DK3541784T5 (da) | 2016-11-18 | 2017-11-17 | Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10875829B1 (https=) |
| EP (1) | EP3541784B1 (https=) |
| JP (1) | JP6990702B2 (https=) |
| CN (1) | CN109963834B (https=) |
| DK (1) | DK3541784T5 (https=) |
| ES (1) | ES2962865T3 (https=) |
| FI (1) | FI3541784T3 (https=) |
| PL (1) | PL3541784T3 (https=) |
| PT (1) | PT3541784T (https=) |
| WO (1) | WO2018091687A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112198237B (zh) * | 2020-05-28 | 2021-08-06 | 扬子江药业集团广州海瑞药业有限公司 | 一种盐酸奈康唑杂质检测控制分析方法 |
| KR20260033020A (ko) | 2023-07-06 | 2026-03-10 | 인터그레이티브 리서치 래버러토리즈 스웨덴 에이비 | 3-(2,3-디플루오로페녹시)아제티딘의 약제학적으로 허용되는 염 및 이의 용도 |
| KR20260033016A (ko) | 2023-07-06 | 2026-03-10 | 인터그레이티브 리서치 래버러토리즈 스웨덴 에이비 | 병리적 무관심의 치료 및/또는 예방에 사용하기 위한 3-(2,3-디플루오로페녹시)아제티딘 또는 이의 약제학적으로 허용되는 염 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1638939A2 (en) * | 2003-06-24 | 2006-03-29 | Neurosearch A/S | Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| AP2007004047A0 (en) | 2005-01-20 | 2007-06-30 | Pfizer Ltd | Substituted triazole derivatives as oxtocin antagonists |
| WO2007148185A2 (en) | 2006-06-21 | 2007-12-27 | Pfizer Products Inc. | Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors |
| WO2010022055A2 (en) | 2008-08-20 | 2010-02-25 | Amgen Inc. | Inhibitors of voltage-gated sodium channels |
| CN102224135A (zh) * | 2008-11-24 | 2011-10-19 | Nsab神经研究瑞典公司分公司 | 用作皮质儿茶酚胺能神经传递调节剂的新3-苯基-氮杂环丁烷衍生物 |
| EP2367787B1 (en) | 2008-11-24 | 2013-01-09 | NSAB, Filial af NeuroSearch Sweden AB, Sverige | 3-phenyl-3-methoxypyrrolidine derivatives as modulators of cortical catecholaminergic neurotransmission |
| WO2010084428A1 (en) | 2009-01-20 | 2010-07-29 | Pfizer Inc. | Substituted pyrazinone amides |
| TWI404721B (zh) * | 2009-01-26 | 2013-08-11 | Pfizer | 胺基－雜環化合物 |
| MX2012009561A (es) * | 2010-02-17 | 2012-11-23 | Amgen Inc | Carboxamidas como inhibidores de canales de sodio dependientes del voltaje. |
| SG195085A1 (en) | 2011-06-07 | 2013-12-30 | Pfizer | Pyrazolo[3,4-d]pyrimidine compounds and their use as pde2 inhibitors and/or cyp3a4 inhibitors |
| KR101273566B1 (ko) | 2011-09-05 | 2013-06-11 | 한국과학기술연구원 | 신규한 아제티딘 유도체 및 이를 함유하는 항우울제 조성물 |
| BR112014018199A8 (pt) * | 2012-01-26 | 2021-03-02 | H Lundbeck As | inibidores da pde9 com cadeia principal imidazo triazinona, composição farmacêutica que os compreende, uso dos referidos inibidores e processo para sua preparação |
| MX2016016488A (es) | 2014-08-27 | 2017-03-30 | Hoffmann La Roche | Derivados de azetidina sustituidos como ligandos de receptores asociados a aminas en trazas (taar). |
| TWI601712B (zh) | 2014-11-05 | 2017-10-11 | 達特神經科學（開曼）有限責任公司 | 作為ｇｌｙｔ１抑制劑之經取代之氮雜環丁基化合物 |
| EP3297987B1 (en) * | 2015-05-20 | 2019-05-15 | Integrative Research Laboratories Sweden AB | Novel azetidine derivatives useful as modulators of cortical cathecolaminergic neurotransmission |
| CN108026030B (zh) | 2015-09-18 | 2020-10-09 | 正大天晴药业集团股份有限公司 | 一种氘代化合物的制备方法 |
| TWI752098B (zh) * | 2016-10-10 | 2022-01-11 | 美商亞雷生物製藥股份有限公司 | 作為ret激酶抑制劑之經取代吡唑并[1,5-a]吡啶化合物 |
-
2017
- 2017-11-17 EP EP17807779.8A patent/EP3541784B1/en active Active
- 2017-11-17 CN CN201780069687.6A patent/CN109963834B/zh active Active
- 2017-11-17 ES ES17807779T patent/ES2962865T3/es active Active
- 2017-11-17 PL PL17807779.8T patent/PL3541784T3/pl unknown
- 2017-11-17 US US16/461,086 patent/US10875829B1/en active Active
- 2017-11-17 WO PCT/EP2017/079666 patent/WO2018091687A1/en not_active Ceased
- 2017-11-17 JP JP2019525851A patent/JP6990702B2/ja active Active
- 2017-11-17 PT PT178077798T patent/PT3541784T/pt unknown
- 2017-11-17 FI FIEP17807779.8T patent/FI3541784T3/fi active
- 2017-11-17 DK DK17807779.8T patent/DK3541784T5/da active
Also Published As
| Publication number | Publication date |
|---|---|
| US10875829B1 (en) | 2020-12-29 |
| JP6990702B2 (ja) | 2022-01-13 |
| CN109963834A (zh) | 2019-07-02 |
| WO2018091687A1 (en) | 2018-05-24 |
| PL3541784T3 (pl) | 2024-03-11 |
| ES2962865T3 (es) | 2024-03-21 |
| EP3541784A1 (en) | 2019-09-25 |
| PT3541784T (pt) | 2023-11-22 |
| EP3541784B1 (en) | 2023-09-13 |
| CN109963834B (zh) | 2023-04-14 |
| FI3541784T3 (fi) | 2023-10-02 |
| JP2019535715A (ja) | 2019-12-12 |
| DK3541784T3 (en) | 2023-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR25C1013I1 (fr) | Macrocycles de diaryle en tant que modulateurs de protéines kinases | |
| LT3728238T (lt) | Sulfonilkarbamido dariniai kaip nlrp3 uždegimo moduliatoriai | |
| PL3507418T3 (pl) | Sposoby biopochodnej derywatyzacji powierzchni celulozowych | |
| EP3347372A4 (en) | PEPTIDOMIMETIC MACROCYCLES AS MODULATORS OF MCL-1 | |
| DK3331876T3 (da) | Modulators of ror-gamma | |
| EP3509581A4 (en) | FORMULATIONS OF (R | |
| FR3021533B1 (fr) | Composition cosmetique de type gel | |
| HUE054009T4 (hu) | Szubsztituált tetrahidrokinolinon vegyületek ROR gamma modulátorként | |
| PT3645518T (pt) | Síntese de omecamtiv mecarbil | |
| EP3360010A4 (en) | BI PHOTONS WITH VOTABLE SOURCE | |
| EP3379139A4 (en) | LAMPHOLDER | |
| PT3457851T (pt) | Derivados de sobetiroma | |
| IL266505B (en) | Heterocyclic modulators of lipid synthesis | |
| EP3430816A4 (en) | FRAME TRANSMISSION | |
| HUE049606T2 (hu) | Eljárás flavonoid inklúziós vegyületek elõállítására | |
| PL3625224T3 (pl) | Pochodne n-podstawionego indolu | |
| BR112016026046A2 (pt) | Uso de compostos de tienotriazolodiazepina | |
| EP3688095A4 (en) | POLYCARBONATE COMPOSITION | |
| FR3023290B1 (fr) | Derives de flavaglines | |
| IL250613B (en) | Substituted bicyclic compounds | |
| PL3717523T3 (pl) | Sposób modyfikacji ldpe | |
| LT3347349T (lt) | Fluorindolo dariniai kaip muskarininio m1 receptoriaus teigiami alosteriniai moduliatoriai | |
| DK3541784T5 (da) | Novel azetidine derivatives useful as modulators of cortical catecholaminergic neurotransmission | |
| EP3288549A4 (en) | GUANFACINE LIQUID ORAL COMPOSITIONS | |
| EP3171860C0 (en) | SOLID ORAL FORMULATION OF FENRETINIDE |